The presence of human herpesvirus 8 (HHV-8) was determined by polymerase chain reaction (PCR) in nasal secretions and saliva from 14 HHV-8-seropositive persons, including 8 Kaposi's sarcoma patients: 7 were human immunodeficiency virus type 1-infected, 6 of whom were asymptomatic. HHV-8 was detected in one or both body fluids in 8 (57%) of 14 subjects. Parallel PCR testing revealed the concomitant presence of cytomegalovirus, Epstein-Barr virus, and HHV-6 in various combinations in these body fluids. These data indicate frequent shedding of multiple herpesviruses in nasal secretions and saliva, particularly in Kaposi's sarcoma patients. Both body fluids are therefore potential sources HHV-8 by nonsexual transmission. by others [3, 6, 7] have also indicated that HHV-8 infection sion.
Epidemiologic evidence suggests that Kaposi's sarcoma
Subjects and Methods (KS) is caused by a sexually transmitted virus. Molecular Fourteen homosexual men were studied. All were infected by [1] and serologic [2 -4] data have implicated human herpes-HIV except 1 who had KS who was HIV-seronegative and who virus 8 (HHV-8) as the etiologic agent of KS. Our seroepidehad a CD4
/ cell count of 869 cells/mL (subject K14). Six subjects miologic studies, using a murine monoclonal antibody -enwere asymptomatic and had a mean CD4 / cell count of 818 cells/ hanced immunofluorescence assay (MIFA) [4] , detected mL (range, 420-1392). The 7 HIV-infected subjects with KS had antigens expressed by a body cavity -based lymphoma a mean CD4
/ cell count of 232 cells/mL (range, 24-609). Thirteen (BCBL-1) cell line carrying HHV-8 but not Epstein-Barr persons were HHV-8-seropositive as determined by MIFA with antibodies to both HHV-8 lytic and latent antigens [4] . One person virus (EBV) [5] . These analyses have determined an age- sion.
The presence of HHV-8 DNA was determined by PCR analyses. Samples were screened using the KS330 233 PCR primer pair, which amplifies a region of KS330Bam [1] . PCR was performed using previously described procedures [9] . The sensitivity of this assay tion were performed to enhance the sensitivity of detection and
The absence of HHV-8 in some nasal fluid and saliva DNA verify the identity of these PCR products. The radiolabeled probes preparations was not due to inhibitors of the PCR because the were derived from amplification products of BCBL-1 as described majority of these same specimens contained PCR-amplifiable above for KS330 233 .
EBV, CMV, and HHV-6 DNA sequences (see below).
To determine nucleotide sequences, amplification products were
Confirmation of HHV-8 in body fluids. DNA prepared from purified following agarose gel electrophoresis, cloned into the TA cloning vector PCR-II (Invitrogen, San Diego), and cycle-senasal fluids and saliva collected at a single visit for 3 subjects (A3, K7, and K8) was also analyzed with HHV-8-specific were detected more frequently in the nasal secretions of the KS patients than in those of the asymptomatic subjects. These primers amplifying two regions of the viral genome designated KS631Bam and T0.7. These samples could be amplified by 3 herpesviruses could also be detected in the saliva (table 2) , confirming previous findings [14] . The 5 HIV-1-infected KS at least two of the three HHV-8-specific PCR primer pairs, confirming the presence of HHV-8 in these fluids and reducing patients analyzed for EBV, CMV, and HHV-6 had 2 or more of these 3 herpesviruses in the saliva. The CD4 / cell counts the likelihood that these data were erroneous due to falsepositive PCR analyses.
were compared for the 4 asymptomatic and 5 KS subjects whose samples were tested for all 4 herpesviruses. This comIndeed, the findings are supported further by the nucleotide sequence analyses of PCR products. The KS330 233 nucleotide parison indicated that the persons with KS (mean, 276 { 256 cells/mL) had statistically significant lower CD4 / cell counts sequence was determined for the DNA prepared from ultracentrifuged samples of saliva from subject K8 and nasal secretions than the asymptomatic persons (mean, 993 { 289 cells/mL) (P Å .0143, Mann-Whitney U test, nonparametric). from 2 subjects (A3 and K7, data not shown). Two types of KS330 233 sequences were identified, one specific to 2 of the The data in tables 1 and 2 show that most of the KS patients analyzed were shedding 3 of the 4 viruses in nasal fluid and/ subjects (A3 and K8) and one identical to that of the HHV-8 that infected BCBL-1. Variations in the deduced amino acid or saliva simultaneously. Two KS patients (K7 and K9) had all 4 viruses present. The overall rate of shedding in the saliva sequence for the patient KS330 233 nucleotide sequence, which differed from that of BCBL-1, were restricted to sites that and nasal secretions for the 6 KS patients evaluated was 100% for EBV, 83% for CMV, and 67% for HHV-8 and HHV-6. In also varied in three other sequences deposited in GenBank (accession nos. U61113, U61114, and U61119). These data contrast, fewer asymptomatic subjects appeared to be shedding multiple herpesviruses, but our sample was too small to be provide further evidence that the results of the present study are not due to false-positive PCR analyses or PCR contamination.
conclusive. Detection of other herpesviruses. Three other human herpesviruses, EBV, CMV, and HHV-6, were detected by PCR Discussion in the nasal secretions (table 2) . Of importance, these viruses
These data indicate that HHV-8 is detectable in either the nasal secretions or saliva from 57% (8/14) of HHV-8-seroposi- Clinical status, subject no. Saliva NS Saliva NS Saliva NS
